Sei Investments Co. Has $6.44 Million Stock Holdings in AdaptHealth Corp. $AHCO

Sei Investments Co. grew its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 17.8% in the 1st quarter, Holdings Channel.com reports. The fund owned 541,331 shares of the company’s stock after purchasing an additional 81,926 shares during the quarter. Sei Investments Co.’s holdings in AdaptHealth were worth $6,442,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Rockefeller Capital Management L.P. raised its holdings in AdaptHealth by 433.0% during the fourth quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock worth $26,000 after acquiring an additional 2,100 shares in the last quarter. PNC Financial Services Group Inc. increased its position in shares of AdaptHealth by 22.3% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock worth $70,000 after purchasing an additional 1,279 shares during the last quarter. Assetmark Inc. increased its position in shares of AdaptHealth by 54.8% during the 1st quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock worth $83,000 after purchasing an additional 2,460 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in shares of AdaptHealth by 318.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after purchasing an additional 7,297 shares in the last quarter. Finally, Tidal Investments LLC bought a new stake in shares of AdaptHealth during the 2nd quarter worth approximately $96,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on AHCO. Wall Street Zen upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Canaccord Genuity Group increased their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Robert W. Baird decreased their price objective on shares of AdaptHealth from $18.00 to $15.00 and set an “outperform” rating for the company in a research report on Monday, July 6th. UBS Group dropped their target price on shares of AdaptHealth from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, May 6th. Finally, Jefferies Financial Group upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating and raised their target price for the company from $11.00 to $13.00 in a research note on Tuesday, July 21st. Seven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $14.14.

AdaptHealth Stock Performance

NASDAQ AHCO opened at $10.83 on Tuesday. The stock has a market cap of $1.47 billion, a PE ratio of -17.47, a P/E/G ratio of 0.55 and a beta of 1.47. The company has a debt-to-equity ratio of 1.21, a quick ratio of 0.71 and a current ratio of 0.92. The firm has a 50-day moving average of $10.29 and a 200-day moving average of $10.68. AdaptHealth Corp. has a 52-week low of $8.51 and a 52-week high of $13.43.

Insiders Place Their Bets

In other AdaptHealth news, insider Russell E. Schuster III sold 11,275 shares of the stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $10.06, for a total value of $113,426.50. Following the transaction, the insider directly owned 136,538 shares of the company’s stock, valued at $1,373,572.28. This represents a 7.63% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is currently owned by corporate insiders.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.